Neurodegeneration with inflammation is accompanied by accumulation of iron and ferritin in microglia and neurons

Neurobiology of Disease

Volumn 81, Issue , 2015, Pages 108-118

  Thomsen, Maj Schneider ^a   Andersen, Michelle Vandborg ^a   Christoffersen, Pia Rægaard ^a   Jensen, Malene Duedal ^a   Lichota, Jacek ^a   Moos, Torben ^a  

^a AALBORG UNIVERSITY   (Denmark)

Author keywords

Ferritin; Hepcidin; Iron; Microglia; Monocyte; Neurodegeneration

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; CD11B ANTIGEN; CELL MARKER; ED1; FERRITIN; FERROPORTIN; GLUTAMIC ACID DERIVATIVE; HEPCIDIN; IBOTENIC ACID; IRON; MESSENGER RNA; UNCLASSIFIED DRUG; ECTODYSPLASIN A; LEUKOCYTE ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN MACROPHAGE; CELL STRUCTURE; CEREBRAL CRUS; CHRONIC INFLAMMATION; CONTROLLED STUDY; CORPUS STRIATUM; ENCEPHALITIS; EXCITOTOXICITY; GLUTAMATERGIC SYNAPSE; IMMUNOREACTIVITY; INFLAMMATORY CELL; IRON METABOLISM; MACROPHAGE; MACROPHAGE MIGRATION; MALE; MICROGLIA; MONOCYTE; NERVE CELL; NERVE CELL NECROSIS; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEREOTACTIC PROCEDURE; SUBSTANTIA NIGRA PARS RETICULATA; SUBTHALAMIC NUCLEUS; ANALYSIS OF VARIANCE; ANIMAL; BRAIN; CHEMICALLY INDUCED; COMPLICATION; DEGENERATIVE DISEASE; DISEASE MODEL; DRUG EFFECTS; GENETICS; METABOLISM; NERVE TRACT; PATHOLOGY; TIME FACTOR; WISTAR RAT;

ANALYSIS OF VARIANCE; ANIMALS; ANTIGENS, CD; BRAIN; DISEASE MODELS, ANIMAL; ECTODYSPLASINS; ENCEPHALITIS; FERRITINS; IBOTENIC ACID; IRON; MALE; MICROGLIA; NEURAL PATHWAYS; NEURODEGENERATIVE DISEASES; RATS; RATS, WISTAR; RNA, MESSENGER; TIME FACTORS;

EID: 84941008828     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2015.03.013     Document Type: Article

References (52)

1. Abboud S., Haile D.J. A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J. Biol. Chem. 2000, 275:19906-19912.
2. Andersen H.H., Johnsen K.B., Moos T. Iron deposits in the chronically inflamed central nervous system and contributes to neurodegeneration. Cell. Mol. Life Sci. 2014, 71:1607-1622.
3. Benkovic S.A., Connor J.R. Ferritin, transferrin, and iron in selected regions of the adult and aged rat brain. J. Comp. Neurol. 1993, 338:97-113.
4. Bostanci M.O., Bagirici F. Neuroprotective effect of aminoguanidine on iron-induced neurotoxicity. Brain Res. Bull. 2008, 76:57-62.
5. Burdo J.R., Menzies S.L., Simpson I.A., Garrick L.M., Garrick M.D., Dolan K.G., Haile D.J., Beard J.L., Connor J.R. Distribution of divalent metal transporter 1 and metal transport protein 1 in the normal and Belgrade rat. J. Neurosci. Res. 2001, 66:1198-1207.
6. Danbolt N.C. Glutamate uptake. Prog. Neurobiol. 2001, 65:1-105.
7. Dexter D.T., Statton S.A., Whitmore C., Freinbichler W., Weinberger P., Tipton K.F., Della Corte L., Ward R.J., Crichton R.R. Clinically available iron chelators induce neuroprotection in the 6-OHDA model of Parkinson's disease after peripheral administration. J. Neural Transm. 2011, 118:223-231.
8. Filomeni G., Bolaños J.P., Mastroberardino P.G. Redox status and bioenergetics liaison in cancer and neurodegeneration. Int. J. Cell Biol. 2012, 2012:659645.
9. Focht S.J., Snyder B.S., Beard J.L., Van Gelder W., Williams L.R., Connor J.R. Regional distribution of iron, transferrin, ferritin, and oxidatively-modified proteins in young and aged Fischer 344 rat brains. Neuroscience 1997, 79:255-261.
10. Good P.F., Olanow C.W., Perl D.P. Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study. Brain Res. 1992, 593:343-346.
11. Good P.F., Perl D.P., Bierer L.M., Schmeidler J. Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study. Ann. Neurol. 1992, 31:286-292.
12. Hansen T.M., Nielsen H., Bernth N., Moos T. Expression of ferritin protein and subunit mRNAs in normal and iron deficient rat brain. Mol. Brain Res. 1999, 65:186-197.
13. Hayflick S.J., Hartman M., Coryell J., Gitschier J., Rowley H. Brain MRI in neurodegeneration with brain iron accumulation with and without PANK2 mutations. AJNR Am. J. Neuroradiol. 2006, 27:1230-1233.
14. Hernandez-Romero M.C., Delgado-Cortes M.J., Sarmiento M., De Pablos R.M., Espinosa-Oliva A.M., Arguelles S., Bandez M.J., Villaran R.F., Maurino R., Santiago M., Venero J.L., Herrera A.J., Cano J., Machado A. Peripheral inflammation increases the deleterious effect of CNS inflammation on the nigrostriatal dopaminergic system. Neurotoxicology 2012, 33:347-360.
15. Hill J.M., Switzer R.C. The regional distribution and cellular localization of iron in the rat brain. Neuroscience 1984, 11:595-603.
16. Jomova K., Vondrakova D., Lawson M., Valko M. Metals, oxidative stress and neurodegenerative disorders. Mol. Cell. Biochem. 2010, 345:91-104.
17. Kroner A., Greenhalgh A.D., Zarruk J.G., Passos Dos Santos R., Gaestel M., David S. TNF and increased intracellular iron alter macrophage polarization to a detrimental M1 phenotype in the injured spinal cord. Neuron 2014, 83:1098-1116.
18. Levi S., Finazzi D. Neurodegeneration with brain iron accumulation: update on pathogenic mechanisms. Front. Pharmacol. 2014, 5:99.
19. Li M., Dai F.R., Du X.P., Yang Q.D., Chen Y. Neuroprotection by silencing iNOS expression in a 6-OHDA model of Parkinson's disease. J. Mol. Neurosci. 2012, 48:225-233.
20. Milligan C.E., Levitt P., Cunningham T.J. Brain macrophages and microglia respond differently to lesions of the developing and adult visual system. J. Comp. Neurol. 1991, 314:136-146.
21. Moos T., Rosengren Nielsen T. Ferroportin in the postnatal rat brain: implications for axonal transport and neuronal export of iron. Semin. Pediatr. Neurol. 2006, 13:149-157.
22. Moos T., Oates P.S., Morgan E.H. Expression of the neuronal transferrin receptor is age dependent and susceptible to iron deficiency. J. Comp. Neurol. 1998, 398:420-430.
23. Moos T., Skjoerringe T., Gosk S., Morgan E.H. Brain capillary endothelial cells mediate iron transport into the brain by segregating iron from transferrin without the involvement of divalent metal transporter 1. J. Neurochem. 2006, 98:1946-1958.
24. Neher J.J., Neniskyte U., Zhao J.W., Bal-Price A., Tolkovsky A.M., Brown G.C. Inhibition of microglial phagocytosis is sufficient to prevent inflammatory neuronal death. J. Immunol. 2011, 186:4973-4983.
25. Nemeth E., Tuttle M.S., Powelson J., Vaughn M.B., Donovan A., Ward D.M., Ganz T., Kaplan J. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004, 306:2090-2093.
26. Nguyen N.B., Callaghan K.D., Ghio A.J., Haile D.J., Yang F. Hepcidin expression and iron transport in alveolar macrophages. Am. J. Physiol. Lung Cell. Mol. Physiol. 2006, 291:L417-L425.
27. Nunez M.T., Urrutia P., Mena N., Aguirre P., Tapia V., Salazar J. Iron toxicity in neurodegeneration. Biometals 2012, 25:761-776.
28. Paxinos G., Watson C. The rat brain in stereotactic coordinates 1986, Academic Press, San Diego.
29. Pelizzoni I., Macco R., Morini M.F., Zacchetti D., Grohovaz F., Codazzi F. Iron handling in hippocampal neurons: activity-dependent iron entry and mitochondria-mediated neurotoxicity. Aging Cell 2011, 10:172-183.
30. Pelizzoni I., Zacchetti D., Smith C.P., Grohovaz F., Codazzi F. Expression of divalent metal transporter 1 in primary hippocampal neurons: reconsidering its role in non-transferrin-bound iron influx. J. Neurochem. 2012, 120:269-278.
31. Peyssonnaux C., Zinkernagel A.S., Datta V., Lauth X., Johnson R.S., Nizet V. TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens. Blood 2006, 107:3727-3732.
32. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29:e45.
33. Pintado C., Revilla E., Vizuete M.L., Jimenez S., Garcia-Cuervo L., Vitorica J., Ruano D., Castano A. Regional difference in inflammatory response to LPS-injection in the brain: role of microglia cell density. J. Neuroimmunol. 2011, 238:44-51.
34. Rathnasamy G., Ling E.A., Kaur C. Consequences of iron accumulation in microglia and its implications in neuropathological conditions. CNS Neurol Disord Drug Targets 2013, 12:785-798.
35. Reif D.W., Simmons R.D. Nitric oxide mediates iron release from ferritin. Arch. Biochem. Biophys. 1990, 283:537-541.
36. Riedlerer P.F. Views on neurodegeneration as a basis for neuroprotective strategies. Med. Sci. Monit. 2004, 10:RA287-RA290.
37. Rouault T.A. Iron metabolism in the CNS: implications for neurodegenerative diseases. Nat. Rev. Neurosci. 2013, 14:551-564.
38. Saji M., Reis D.J. Delayed transneuronal death of substantia nigra neurons prevented by gamma-aminobutyric acid agonist. Science 1987, 235:66-69.
39. Sastry S., Arendash G.W. Time-dependent changes in iron levels and associated neuronal loss within the substantia nigra following lesions within the neostriatum/globus pallidus complex. Neuroscience 1995, 67:649-666.
40. Simpson I.A., Ponnuru P., Klinger M.E., Myers R.L., Devraj K., Coe C.L., Lubach G.R., Carruthers A., Connor J.R. A novel model for brain iron uptake: introducing the concept of regulation. J. Cereb. Blood Flow Metab. 2015, 35(1):48-57.
41. Sofic E., Riederer P., Heinsen H., Beckmann H., Reynolds G.P., Hebenstreit G., Youdim M.B. Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain. J. Neural Transm. 1988, 74:199-205.
42. Stoger J.L., Goossens P., De Winther M.P. Macrophage heterogeneity: relevance and functional implications in atherosclerosis. Curr. Vasc. Pharmacol. 2010, 8:233-248.
43. Tabas I., Seimon T., Timmins J., Li G., Lim W. Macrophage apoptosis in advanced atherosclerosis. Ann. N. Y. Acad. Sci. 2009, 1173(Suppl. 1):E40-E45.
44. Theurl I., Theurl M., Seifert M., Mair S., Nairz M., Rumpold H., Zoller H., Bellmann-Weiler R., Niederegger H., Talasz H., Weiss G. Autocrine formation of hepcidin induces iron retention in human monocytes. Blood 2008, 111:2392-2399.
45. Urrutia P., Aguirre P., Esparza A., Tapia V., Mena N.P., Arredondo M., Gonzalez-Billault C., Nunez M.T. Inflammation alters the expression of DMT1, FPN1 and hepcidin, and it causes iron accumulation in central nervous system cells. J. Neurochem. 2013, 126:541-549.
46. Uversky V.N., Li J., Fink A.L. Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure. J. Biol. Chem. 2001, 276:44284-44296.
47. Wang W., Fan L., Xu D., Wen Z., Yu R., Ma Q. Immunotherapy for Alzheimer's disease. Acta Biochim. Biophys. Sin. (Shanghai) 2012, 44:807-814.
48. Ward R.J., Zucca F.A., Duyn J.H., Crichton R.R., Zecca L. The role of iron in brain ageing and neurodegenerative disorders. Lancet Neurol. 2014, 13:1045-1060.
49. Wirenfeldt M., Dissing-Olesen L., Anne Babcock A., Nielsen M., Meldgaard M., Zimmer J., Azcoitia I., Leslie R.G., Dagnaes-Hansen F., Finsen B. Population control of resident and immigrant microglia by mitosis and apoptosis. Am. J. Pathol. 2007, 171:617-631.
50. Wu L.J., Leenders A.G., Cooperman S., Meyron-Holtz E., Smith S., Land W., Tsai R.Y., Berger U.V., Sheng Z.H., Rouault T.A. Expression of the iron transporter ferroportin in synaptic vesicles and the blood-brain barrier. Brain Res. 2004, 1001:108-117.
51. Zecca L., Youdim M.B., Riederer P., Connor J.R., Crichton R.R. Iron, brain ageing and neurodegenerative disorders. Nat. Rev. Neurosci. 2004, 5:863-873.
52. Zhang D.L., Hughes R.M., Ollivierre-Wilson H., Ghosh M.C., Rouault T.A. A ferroportin transcript that lacks an iron-responsive element enables duodenal and erythroid precursor cells to evade translational repression. 2009, 9:461-473.